β-Carotene metabolites enhance inflammation-induced oxidative DNA damage in lung epithelial cells

Free Radical Biology and Medicine

Volumn 46, Issue 2, 2009, Pages 299-304

  van Helden, Yvonne G J ^a,b   Keijer, Jaap ^b   Knaapen, Ad M ^a   Heil, Sandra G ^b   Briedé, Jacob J ^a   van Schooten, Frederik J ^a   Godschalk, Roger W L ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Tocopherol; Carotene; Carcinogenesis; EPR; ESR; FPG comet; Free radicals; Hydroxyl radical; Inflammation; Lung; Myeloperoxidase; Retinal; Retinoic acid; Retinol; Superoxide anion; Vitamin A; Vitamin E

Indexed keywords

BETA CAROTENE; CATALASE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; HYDROGEN PEROXIDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; RETINOL;

ADULT; ARTICLE; CELL ACTIVATION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; ELECTRON SPIN RESONANCE; EPITHELIUM CELL; FEMALE; FENTON REACTION; GENOTOXICITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MALE; NEUTROPHIL; PRIORITY JOURNAL;

BETA CAROTENE; CELL LINE, TUMOR; CELL MOVEMENT; DNA DAMAGE; ELECTRON SPIN RESONANCE SPECTROSCOPY; EPITHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; MUTAGENICITY TESTS; NEUTROPHIL ACTIVATION; NEUTROPHILS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE; PURINES; TRETINOIN; VITAMIN A;

EID: 58049087184     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.10.038     Document Type: Article

References (48)

1. van Poppel G. Epidemiological evidence for beta-carotene in prevention of cancer and cardiovascular disease. Eur. J. Clin. Nutr. 50 Suppl. 3 (1996) S57-S61
2. Ziegler R.G. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J. Nutr. 119 (1989) 116-122
3. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens Jr. F.L., Valanis B., Williams Jr. J.H., Barnhart S., Cherniack M.G., Brodkin C.A., and Hammar S. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer. Inst. 88 (1996) 1550-1559
4. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Palmgren J., Freedman L.S., Haapakoski J., Barrett M.J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E.R., Tangrea J.A., Teppo L., Askin F.B., Taskinen E., Erozan Y., Greenwald P., and Huttunen J.K. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88 (1996) 1560-1570
5. Baron J.A., and Sandler R.S. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 51 (2000) 511-523
6. Pereg D., and Lishner M. Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J. Intern. Med. 258 (2005) 115-123
7. Thun M.J., Henley S.J., and Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94 (2002) 252-266
8. Schwartz A.G., Prysak G.M., Bock C.H., and Cote M.L. The molecular epidemiology of lung cancer. Carcinogenesis 28 (2007) 507-518
9. Brody J.S., and Spira A. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 3 (2006) 535-537
10. Harris R.E., Beebe-Donk J., and Schuller H.M. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol. Rep. 9 (2002) 693-695
11. Muscat J.E., Chen S.Q., Richie Jr. J.P., Altorki N.K., Citron M., Olson S., Neugut A.I., and Stellman S.D. Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer 97 (2003) 1732-1736
12. Doerschuk C.M. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8 (2001) 71-88
13. Knaapen A.M., Gungor N., Schins R.P., Borm P.J., and Van Schooten F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21 (2006) 225-236
14. Jackson J.H., Gajewski E., Schraufstatter I.U., Hyslop P.A., Fuciarelli A.F., Cochrane C.G., and Dizdaroglu M. Damage to the bases in DNA induced by stimulated human neutrophils. J. Clin. Invest. 84 (1989) 1644-1649
15. Spencer J.P., Whiteman M., Jenner A., and Halliwell B. Nitrite-induced deamination and hypochlorite-induced oxidation of DNA in intact human respiratory tract epithelial cells. Free Radic. Biol. Med. 28 (2000) 1039-1050
16. Gutteridge J.M., and Halliwell B. Free radicals and antioxidants in the year 2000: a historical look to the future. Ann. N. Y. Acad. Sci. 899 (2000) 136-147
17. Schraufstatter I., Hyslop P.A., Jackson J.H., and Cochrane C.G. Oxidant-induced DNA damage of target cells. J. Clin. Invest. 82 (1988) 1040-1050
18. Knaapen A.M., Schins R.P., Borm P.J., and van Schooten F.J. Nitrite enhances neutrophil-induced DNA strand breakage in pulmonary epithelial cells by inhibition of myeloperoxidase. Carcinogenesis 26 (2005) 1642-1648
19. Rahman I., Biswas S.K., and Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 533 (2006) 222-239
20. von Lintig J., Hessel S., Isken A., Kiefer C., Lampert J.M., Voolstra O., and Vogt K. Towards a better understanding of carotenoid metabolism in animals. Biochim. Biophys. Acta 1740 (2005) 122-131
21. Albanes D., Malila N., Taylor P.R., Huttunen J.K., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Barrett M.J., Pietinen P., Hartman T.J., Sipponen P., Lewin K., Teerenhovi L., Hietanen P., Tangrea J.A., Virtanen M., and Heinonen O.P. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control 11 (2000) 197-205
22. Wilms L.C., Kleinjans J.C., Moonen E.J., and Briede J.J. Discriminative protection against hydroxyl and superoxide anion radicals by quercetin in human leucocytes in vitro. Toxicol. In Vitro 22 (2008) 301-307
23. Klebanoff S.J., Waltersdorph A.M., and Rosen H. Antimicrobial activity of myeloperoxidase. Methods Enzymol. 105 (1984) 399-403
24. Knaapen A.M., Seiler F., Schilderman P.A., Nehls P., Bruch J., Schins R.P., and Borm P.J. Neutrophils cause oxidative DNA damage in alveolar epithelial cells. Free Radic. Biol. Med. 27 (1999) 234-240
25. Morikawa K., Shimokawa H., Matoba T., Kubota H., Akaike T., Talukder M.A., Hatanaka M., Fujiki T., Maeda H., Takahashi S., and Takeshita A. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J. Clin. Invest. 112 (2003) 1871-1879
26. Klebanoff S.J. Myeloperoxidase. Proc. Assoc. Am. Physicians 111 (1999) 383-389
27. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., and Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271 (1996) 14412-14420
28. Van Schooten F.J., Boots A.W., Knaapen A.M., Godschalk R.W., Maas L.M., Borm P.J., Drent M., and Jacobs J.A. Myeloperoxidase (MPO) - 463 G → A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 828-833
29. Lu W., Qi J., Xing D., Tan W., Miao X., Su W., Wu M., and Lin D. [Lung cancer risk associated with genetic polymorphism in myeloperoxidase (- 463 G/A) in a Chinese population]. Zhonghua Zhong Liu Za Zhi 24 (2002) 250-253
30. Schabath M.B., Spitz M.R., Zhang X., Delclos G.L., and Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 21 (2000) 1163-1166
31. Misra R.R., Tangrea J.A., Virtamo J., Ratnasinghe D., Andersen M.R., Barrett M., Taylor P.R., and Albanes D. Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett. 164 (2001) 161-167
32. Mateos F., Brock J.H., and Perez-Arellano J.L. Iron metabolism in the lower respiratory tract. Thorax 53 (1998) 594-600
33. Upadhyay D., and Kamp D.W. Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp. Biol. Med. (Maywood) 228 (2003) 650-659
34. Hampton M.B., Kettle A.J., and Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92 (1998) 3007-3017
35. Garcia-Casal M.N., Leets I., and Layrisse M. Beta-carotene and inhibitors of iron absorption modify iron uptake by Caco-2 cells. J. Nutr. 130 (2000) 5-9
36. Prakash P., Jackson C.L., and Gerber L.E. Subcellular accumulation of beta-carotene and retinoids in growth-inhibited NCI-H69 small cell lung cancer cells. Nutr. Cancer 34 (1999) 76-82
37. Polyakov N.E., Leshina T.V., Konovalova T.A., and Kispert L.D. Carotenoids as scavengers of free radicals in a Fenton reaction: antioxidants or pro-oxidants?. Free Radic. Biol. Med. 31 (2001) 398-404
38. Redlich C.A., Chung J.S., Cullen M.R., Blaner W.S., Van Bennekum A.M., and Berglund L. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis 145 (1999) 425-432
39. Redlich C.A., Blaner W.S., Van Bennekum A.M., Chung J.S., Clever S.L., Holm C.T., and Cullen M.R. Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 211-214
40. Franssen-van Hal N.L., Bunschoten J.E., Venema D.P., Hollman P.C., Riss G., and Keijer J. Human intestinal and lung cell lines exposed to beta-carotene show a large variation in intracellular levels of beta-carotene and its metabolites. Arch. Biochem. Biophys. 439 (2005) 32-41
41. Goralczyk R., Wertz K., Lenz B., Riss G., Buchwald Hunziker P., Geatrix B., Aebischer C.P., and Bachmann H. Beta-carotene interaction with NNK in the AJ-mouse model: effects on cell proliferation, tumor formation and retinoic acid responsive genes. Biochim. Biophys. Acta 1740 (2005) 179-188
42. Napoli J.L. Quantification of physiological levels of retinoic acid. Methods Enzymol. 123 (1986) 112-124
43. Kurlandsky S.B., Gamble M.V., Ramakrishnan R., and Blaner W.S. Plasma delivery of retinoic acid to tissues in the rat. J. Biol. Chem. 270 (1995) 17850-17857
44. Ross A.C. On the sources of retinoic acid in the lung: understanding the local conversion of retinol to retinoic acid. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L247-L248
45. Siems W., Wiswedel I., Salerno C., Crifo C., Augustin W., Schild L., Langhans C.D., and Sommerburg O. Beta-carotene breakdown products may impair mitochondrial functions-potential side effects of high-dose beta-carotene supplementation. J. Nutr. Biochem. 16 (2005) 385-397
46. Sommerburg O., Langhans C.D., Arnhold J., Leichsenring M., Salerno C., Crifo C., Hoffmann G.F., Debatin K.M., and Siems W.G. Beta-carotene cleavage products after oxidation mediated by hypochlorous acid-a model for neutrophil-derived degradation. Free Radic. Biol. Med. 35 (2003) 1480-1490
47. Krinsky N.I., and Yeum K.J. Carotenoid-radical interactions. Biochem. Biophys. Res. Commun. 305 (2003) 754-760
48. Palozza P., Serini S., Di Nicuolo F., Piccioni E., and Calviello G. Prooxidant effects of beta-carotene in cultured cells. Mol. Aspects Med. 24 (2003) 353-362